SCANCELL HLDGS PLC ORD GBP0.001SCANCELL HLDGS PLC ORD GBP0.001SCANCELL HLDGS PLC ORD GBP0.001

SCANCELL HLDGS PLC ORD GBP0.001

No trades
See on Supercharts

SCLP fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. Its vaccine platform includes Moditope and ImmunoBody. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

SCLP does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company